NewsVandana Singh
Intelligent Bio Solutions
INBS · NASDAQ
$1.67+$0.14 (+9.15%)TodayMarket closed ·
Prev close $1.53
Latest news
- Press releaseGlobe Newswire
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseGlobe Newswire
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
- Press releaseGlobe Newswire
Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
- NewsHenry Khederian
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?
- News
Intelligent Bio Solutions' Intelligent Fingerprinting Drug Screening Business Has Been ISO Recertified To The 13485:2016 Quality Management System Standard And Will Be Valid For Three Years
- Press releaseGlobe Newswire
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
- Press releaseGlobe Newswire
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- NewsAvi Kapoor
Crude Oil Falls 1%; US Manufacturing Growth Eases In December
- NewsVandana Singh
What's Going On With Intelligent Bio Stock Friday?
- NewsAvi Kapoor
Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Nasdaq Moves Lower; US Crude Oil Inventories Decline Sharply
- NewsAvi Kapoor
Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- NewsAvi Kapoor
Dow Falls 50 Points; US Initial Jobless Claims Decline
- NewsVandana Singh
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
- NewsVandana Singh
EXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
- NewsVandana Singh
EXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch
- NewsVandana Singh
EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout
- Press releaseGlobe Newswire
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Harry Simeonidis, President and CEO of Intelligent Bio Solutions Inc.
- NewsVandana Singh
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales
- Press releaseGlobe Newswire
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
- NewsAvi Kapoor
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
- NewsAvi Kapoor
US Stocks Higher; Dow Surges Over 200 Points
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.